found that EGFR/MAPK signaling is essential for maintaining the stemness and proliferation potential of glioma stem cells, and its inhibition can induce cell differentiation and reduce the tumor stem cell phenotype (69). This evidence concerns the gene EGFR and central nervous system cancer.